The stock is trading within its historically normalranges of both price-to-sales and price-to-cash earnings, so there is nothing particularly intriguing from a historical valuation standpoint.
It is encouraging that the characteristics of this group of cloned calves apparently fall within normalranges, although in some cases the data is presented in a way that does not show variation.
The stock is very near the high end of its historically normalranges of both price-to-cash earnings and price-to-sales, which suggests the market has already priced in quite a bit of fundamental improvement.
PetSmart is trading within its historically normal price-to-cash earnings and price-to-sales ranges as the market has finally rewarded PETM for its steady growth.